Altered growth responses of pulmonary artery smooth muscle cells from patients with primary pulmonary hypertension to transforming growth factor-beta(1) and bone morphogenetic proteins
about
BMP4 induces HO-1 via a Smad-independent, p38MAPK-dependent pathway in pulmonary artery myocytesBone morphogenetic protein (BMP) and activin type II receptors balance BMP9 signals mediated by activin receptor-like kinase-1 in human pulmonary artery endothelial cellsMolecular pathogenesis of pulmonary arterial hypertensionDirect signaling by the BMP type II receptor via the cytoskeletal regulator LIMK1New insights into the pathogenesis and treatment of primary pulmonary hypertensionA Survey of Strategies to Modulate the Bone Morphogenetic Protein Signaling Pathway: Current and Future PerspectivesPulmonary Hypertension and Indicators of Right Ventricular FunctionTargeting BMP signalling in cardiovascular disease and anaemiaA comprehensive review: the evolution of animal models in pulmonary hypertension research; are we there yet?Linking a serotonin transporter polymorphism to vascular smooth muscle proliferation in patients with primary pulmonary hypertensionDownregulation of type II bone morphogenetic protein receptor in hypoxic pulmonary hypertensionBmp2 and Bmp4 exert opposing effects in hypoxic pulmonary hypertensionRegulation and function of miR-214 in pulmonary arterial hypertension.MicroRNA-140-5p and SMURF1 regulate pulmonary arterial hypertension.Overexpression of human bone morphogenetic protein receptor 2 does not ameliorate monocrotaline pulmonary arterial hypertension.Sex differences in the pulmonary circulation: implications for pulmonary hypertensionTGF beta and IL13 in Schistosomiasis mansoni associated pulmonary arterial hypertension; a descriptive study with comparative groups.Adenosine A2B receptor and hyaluronan modulate pulmonary hypertension associated with chronic obstructive pulmonary diseaseGenomewide RNA expression profiling in lung identifies distinct signatures in idiopathic pulmonary arterial hypertension and secondary pulmonary hypertension.Transient but not genetic loss of miR-451 is protective in the development of pulmonary arterial hypertensionGene therapy targeting survivin selectively induces pulmonary vascular apoptosis and reverses pulmonary arterial hypertension.Basic science of pulmonary arterial hypertension for clinicians: new concepts and experimental therapiesHeritable forms of pulmonary arterial hypertension.Lung ¹⁸F-fluorodeoxyglucose positron emission tomography for diagnosis and monitoring of pulmonary arterial hypertensionIdentification of a common Wnt-associated genetic signature across multiple cell types in pulmonary arterial hypertension.BMP4 protects rat pulmonary arterial smooth muscle cells from apoptosis by PI3K/AKT/Smad1/5/8 signaling.Transforming growth factor-β inhibition attenuates pulmonary arterial hypertension in rats.BMP-2 up-regulates PTEN expression and induces apoptosis of pulmonary artery smooth muscle cells under hypoxiaNovel promoter and exon mutations of the BMPR2 gene in Chinese patients with pulmonary arterial hypertension.Divergent effects of BMP-2 on gene expression in pulmonary artery smooth muscle cells from normal subjects and patients with idiopathic pulmonary arterial hypertension.BMP promotes motility and represses growth of smooth muscle cells by activation of tandem Wnt pathwaysModification of hemodynamic and immune responses to exposure with a weak antigen by the expression of a hypomorphic BMPR2 geneNew treatments for pulmonary arterial hypertension.New perspectives for the treatment of pulmonary hypertensionMassive occlusive thrombosis of the pulmonary artery in pigtailed macaques chronically infected with R5-tropic simian-human immunodeficiency virus.Heterozygous null bone morphogenetic protein receptor type 2 mutations promote SRC kinase-dependent caveolar trafficking defects and endothelial dysfunction in pulmonary arterial hypertension.Vasoactive intestinal peptide as a new drug for treatment of primary pulmonary hypertensionInsights into the genetic and molecular basis of primary pulmonary hypertension.Deficiency of Akt1, but not Akt2, attenuates the development of pulmonary hypertension.Disruption of PPARγ/β-catenin-mediated regulation of apelin impairs BMP-induced mouse and human pulmonary arterial EC survival
P2860
Q24315830-9E147CEE-C587-480C-B14C-4DC40AC1BD1DQ24315838-CDDD7478-D9F5-418A-B22D-DB818D3BBC6DQ24634317-40EA16BD-B0E4-4469-BD06-4D3D60503586Q24675335-5696BE5B-CAF1-4AA9-A5D9-E92722242711Q24679149-304706E3-CF4C-4FC6-B2E1-D1E862CA551BQ26739015-4FBA798B-7F14-4A3D-ACB9-716E1AE57281Q26744781-F1CBF011-677B-4A1E-A59C-F417EC7BBB7DQ26783734-93B40EE7-A8A6-4733-B3A1-ADE863F482BEQ27026643-7FB63D24-4ECC-4231-9B4F-AF306DF724FEQ28361811-D13FBDB7-525D-4723-ACFF-E3C067A5CBAAQ28572271-B96B5F0A-B286-4207-9485-14B64A7807B7Q28594843-DABADAAD-4E66-4EED-853D-C04C1A88F690Q32884388-9DC1FC5F-AF21-41E8-9B6A-566B2AB4F857Q32884516-6DA0E6BD-0707-4A07-8C9B-82F79216CF1CQ33265315-B3493660-EF2A-4AD9-901B-8B842DA7E248Q33568826-8C7627A4-9A7F-42C1-B583-FEA6B2FB79AFQ33712505-D390C334-88C5-4150-A0BA-A798362BED23Q33765096-6C45C720-F42A-4114-874C-0C1AB816C160Q33784417-3AABDED3-214F-4E88-9E44-CB53CF6113FFQ33806212-083EC294-72A8-489D-BD34-7712CEE9297BQ33831900-E7A5231B-7AFE-4BA5-9B59-E3CEC75CA4D7Q33849207-6B8C8343-FC9C-41AC-BE1D-D9CDA22CB4E2Q33915567-D68046E5-2D40-426A-AE9E-A6495D119BDAQ34127884-17AABDF6-C3AB-4C12-A0DA-F7DC3F3862B1Q34130859-CD8CA4E2-8F5F-4719-8838-29C4024B97B1Q34158444-41F680E7-C8A5-4D5D-BDA6-57FDE528F513Q34271256-259AA7DB-2675-44D2-82CE-574AAB30E7CFQ34277172-BD167ED4-A1C0-4E9F-8929-14D267EE189AQ34326955-254CED93-5D73-411F-94D9-1A0417BDAD75Q34468421-7EC5D904-CC34-4686-BEB8-D06E09D2673AQ34483074-BAA1354C-515D-4BC7-8322-FDCC78F691B0Q34576173-08A60228-9175-4F00-8C33-D6A24B4D6E2BQ34625826-278EFFC8-B49E-43CB-B13D-E80A9F872B33Q34903204-7D4518C2-2BE6-4C05-9F1D-DB7CFD585626Q34945054-8244EBA4-0289-4C6F-8EF8-78BD9EFC4415Q34958933-A773745E-9DCD-4781-B27F-9994ED11EB66Q34985266-4DDFA5CE-1898-45B0-84BD-EFF41935467EQ35079425-A27D1F92-02F9-4BB8-9829-3F6878C59732Q35115837-CDC8F2D4-A445-48F2-BB25-9867FBE54160Q35187029-3675B8AF-BC61-43EC-A16D-55F16530C413
P2860
Altered growth responses of pulmonary artery smooth muscle cells from patients with primary pulmonary hypertension to transforming growth factor-beta(1) and bone morphogenetic proteins
description
2001 nî lūn-bûn
@nan
2001 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Altered growth responses of pu ...... nd bone morphogenetic proteins
@ast
Altered growth responses of pu ...... nd bone morphogenetic proteins
@en
Altered growth responses of pu ...... nd bone morphogenetic proteins
@en-gb
Altered growth responses of pu ...... nd bone morphogenetic proteins
@nl
type
label
Altered growth responses of pu ...... nd bone morphogenetic proteins
@ast
Altered growth responses of pu ...... nd bone morphogenetic proteins
@en
Altered growth responses of pu ...... nd bone morphogenetic proteins
@en-gb
Altered growth responses of pu ...... nd bone morphogenetic proteins
@nl
prefLabel
Altered growth responses of pu ...... nd bone morphogenetic proteins
@ast
Altered growth responses of pu ...... nd bone morphogenetic proteins
@en
Altered growth responses of pu ...... nd bone morphogenetic proteins
@en-gb
Altered growth responses of pu ...... nd bone morphogenetic proteins
@nl
P2093
P921
P3181
P356
P1433
P1476
Altered growth responses of pu ...... nd bone morphogenetic proteins
@en
P2093
P304
P3181
P356
10.1161/HC3201.094152
P407
P577
2001-08-01T00:00:00Z